Mixtard 30 vial 100IU/ml Insulin

Treatment of all type 1 diabetic patient. Treatment for those with type 2 diabetes whose blood sugar cannot be sufficiently controlled by diet or oral hypoglycemic medications. For the initial stabilization of diabetes in people with diabetic ketoacidosis, hyperosmolar non-ketotic syndrome, and during stressful times like serious illnesses and major surgery for people with diabetes. Gestational diabetes treatment.

Isophane Insulin Human 30/70 Injection with Insulin Human (rDNA) Insulin Human (rDNA) USP 40 IU (equal to 1.388 mg) is present in each milliliter of solution as 30% Soluble Insulin Human (Regular) and 70% Isophane Insulin Human. Isophane Insulin Human 30/70 Injection with Insulin Human (rDNA) Insulin Human (rDNA) USP 100 IU (equal to 3.47 mg) is present in each milliliter of solution as 30% Soluble Insulin Human (Regular) and 70% Isophane Insulin Human. 50/50 Injection of Insulin Human (rDNA) and Isophane Insulin Human (rDNA) USP 100 IU (equal to 3.47 mg) is present in each milliliter of solution as 50% soluble Insulin Human (Regular) and 50% isophane Insulin Human.

Insulin with a Medium Action.

Human insulin is produced using recombinant DNA technology as Insulin Human (rDNA). It works and is structurally identical to natural insulin. Insulin controls how glucose is metabolized and promotes the absorption and use of glucose by the liver, muscles, and fat. By promoting glycogenesis and preventing gluconeogenesis, it also reduces blood sugar levels. After injection, insulin human (rDNA) 30/70 and insulin human (rDNA) 50/50 begin to work within 30 minutes, reach their peak levels between 2 and 8 hours later, and persist for roughly 24 hours.